认知障碍是老年人身体表现下降的危险因素
Dan Su1,2, Ying Liu3, Yangling Su1
1Department of Geriatrics, Liangxiang Hospital of Beijing Fangshan District, Beijing, 102400, China.
Heliyon
|June 13, 2024
概括
新的认知障碍显著增加了老年人身体表现下降的风险. 针对认知的干预措施可以促进老年人的健康衰老.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 神经学 神经学
背景情况:
- 随着年龄的增长,身体表现下降,影响老年人的独立性.
- 了解影响身体衰退的因素对于健康老龄化计划至关重要.
研究的目的:
- 为了检查北京社区居住的老年人的3年身体表现轨迹.
- 为了确定与体力表现下降相关的不良事件.
主要方法:
- 在3年内对456名社区长老进行了长度观察研究.
- 使用迷你心理状态检查 (MMSE) 评估认知,使用短物理性能电池 (SPPB) 评估身体表现.
- 多变量逻辑回归分析了新不良事件与身体性能变化之间的关联.
主要成果:
- 身体表现不佳的老年人比例从26.97%上升到42.11%.
- 良好的体力表现从44.96%下降到30.48%.
- 新发性认知障碍独立预测身体表现恶化 (OR:5.17).
结论:
- 认知障碍是老年人身体能力下降的重要独立风险因素.
- 针对认知障碍的有针对性的干预措施可以增强健康的衰老和保持身体功能.
相关概念视频
Cognitive Development During Adulthood
88
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
88
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Aging
41
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
41
Negative and Cognitive Symptoms of Schizophrenia
48
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
48
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462


